Natalie D. Vernon

Cooley Advised SoundThinking on Agreement to be Acquired by Transom Capital Group

Cooley advised SoundThinking, a leading public safety technology company combining transformative solutions and strategic advisory services for law enforcement and civic leadership, on its agreement to be acquired by Transom Capital Group, Rubin an operationally focused middle-market private equity firm. Upon completion of the merger, Transom will commence a tender offer to acquire all outstanding shares of SoundThinking’s common stock for a purchase price of $8.00 per share in cash, payable at closing, plus one non-transferable CVR, which entitles each holder thereof to receive up to an additional $3.00 per share in cash, payable upon achievement of certain revenue milestones. SoundThinking’s shares will no longer trade on Nasdaq, and SoundThinking will become a privately held company.

Cooley advised Personalis, a company transforming the active management of cancer through breakthrough personalized testing, on its agreement to be acquired by Tempus AI, a technology company leading the adoption of AI to advance precision medicine and patient care, based on an equity value for Personalis of $1.9 billion.

Cooley advised GPTZero, a leading AI content detector with a comprehensive authenticity suite, on its agreement to be acquired by Superhuman, the productivity platform bringing AI to wherever people work.

Cooley advised Curevo Vaccine, a clinical-stage biotechnology company dedicated to developing varicella zoster virus (VZV) vaccines with improved tolerability, on its acquisition by Eli Lilly and Company for up to $1.5 billion.

Cooley advised 35Pharma, a Canada-based, private, clinical-stage biopharmaceutical company that specializes in developing novel protein-based therapeutics, on its agreement to be acquired by GSK for $950 million.